Science devoted to the ones we love
Innovating Solutions for Neurodegenerative Diseases
MagQu is dedicated to transforming the landscape of neurodegenerative disease diagnostics. With our pioneering immunomagnetic reduction (IMR) technology, we provide highly sensitive and reliable tools for the early detection of Alzheimer's disease and other debilitating conditions. By focusing on precision and comprehensive biomarker analysis, we empower clinicians and individuals to make informed decisions for proactive care and a clearer path forward.
MagQu: Delivering Clarity
Precision Detection
Highly sensitive, reliable biomarker analysis
Extensive Analysis
Complete view for accurate assessment.
Accessible Testing
Less invasive, convenient blood tests
Early Insights
Enables early detection of biomarkersAbout
MagQu
100+
SCI papers
29
4
Patents
Certifications
From Innovation into Practice
MagQu focuses on creating new technologies and novel products. To do this, MagQu forms an interdisciplinary R&D team, as well as cooperates with professional institutes or experts in the areas of bio-chemistry, protein, nanomaterials, magnetism, electric engineering, software programming, laboratory medicine, clinic medicine, aquaculture etc. So far, MagQu has created more than six innovative technologies and has made them commercialized. Through the marketing of these novel products, MagQu continuously increases its value, and keeps itself at the leading position in the relevant markets.
Congratulations to the Nobel Laureates!
MagQu SQUID Technology Rooted in Quantum Frontier
MagQu extends heartfelt congratulations to UC Berkeley Emeritus Professor John Clarke on being awarded the 2025 Nobel Prize in Physics for his foundational work on Macroscopic Quantum Tunnelling.
Dr. Charles S.Y. Yang, MagQu Founder, is greatly inspired by Professor Clarke’s recognition. Dr. Yang emphasized that Professor Clarke is not only a pioneer in superconducting electronics but also a long-time friend. Professor Clarke witnessed MagQu's early entrepreneurship and visited the company in 2013 to show his concern, which established a robust scientific base for our SQUID technology.
This legacy of Nobel-caliber science is reflected in the technical implementation of the MagQu Magnetic Immunoassay Analyzer (XacPro-S):
Technical Specifications: The instrument incorporates quantum-effect-based SQUID magnetic sensors, aiming for ultra-high sensitivity quantification of extremely low-concentration biomolecules.
Application Scope: The technology is applied in the detection of Alzheimer's biomarkers such as Tau protein and Aβ1−42 in samples like plasma, with a specified sensitivity better than 1 pg/ml.
Learn more about MagQu
-
For Researchers
-
For Patients & Families
Contact Us
Interested in working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!